Aumnic

Aumnic is an AI-driven biotechnology company focused on accelerating drug discovery through the use of foundation models for biology and regulatory genomics. Founded by leading researchers from Stanford University, the company leverages advanced machine learning to decode the complex language of the genome and identify novel therapeutic targets. Aumnic's platform integrates large-scale biological data with generative AI to design optimized molecules for challenging diseases, particularly in oncology and immunology. The company operates at the intersection of big tech and life sciences, aiming to transform the traditional drug discovery paradigm into a more predictable and efficient process.